OR WAIT null SECS
February 24, 2022
MilliporeSigma and Waters will work together to build an extractables and leachables (E&L) reference library.
Scottish Enterprise has awarded £20 million (US$27 million) to Valneva Scotland to advance vaccine development.
February 23, 2022
Alvea has begun preclinical testing of a scalable, shelf-stable DNA vaccine against SARS-CoV-2 variants.
Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.
Sanofi and GSK announce they are seeking regulatory authorization for COVID-19 vaccine.
MHRA has opened a consultation on the proposed changes to clinical trial legislation in the UK.
Novavax announces the first doses of Nuvaxovid COVID-19 vaccine have begun shipping to European Union member states.
The Center for Breakthrough Medicines and BioAnalysis LLC have formed a strategic alliance to offer novel analytical testing services for CGT clients.
Semarion raises £2.14 million GBP (US$2.89 million) seed funding to support the commercial development of Semarion’s SemaCyte cell assaying platform.
February 22, 2022
Noema Pharma announces first patient dosed in its Phase IIb clinical trial of mGluR5 inhibitor NOE-101 in trigeminal neuralgia.